BMI OrganBank Secures $3.5 Million NIH Grant to Advance Innovative Kidney Preservation Technology Towards Clinical Trials

WINSTON-SALEM, N.C., Feb. 13, 2025 /PRNewswire/ -- BMI OrganBank, a medtech company advancing integrated organ preservation and assessment systems, today announced it has secured a $3.5 million grant from the National Institutes of Health (NIH) to support the development and clinical translation of its innovative kidney preservation technology. The grant will fund preclinical studies and regulatory preparation activities necessary to advance BMI OrganBank's room-temperature machine perfusion platform toward first-in-human clinical trials. The company's technology aims to significantly extend organ preservation times and improve transplant outcomes by maintaining organs in a physiologically active state. "This NIH funding is a strong validation of our technology's potential to address the critical organ shortage," said Carrie DiMarzio, CEO and Co-Founder of BMI OrganBank. "We are committed to bringing this breakthrough technology to patients as quickly as possible."